HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CC Investors Who Suffered Substantial Losses to Contact Firm's Attorneys Investigating Possible Securities Law Violations
San Francisco, California--(Newsfile Corp. - March 5, 2024) - Hagens Berman urges The Chemours Company (NYSE: CC) investors who suffered substantial losses to submit your losses now.
Visit: www.hbsslaw.com/investor-fraud/CC
Contact An Attorney Now: CC@hbsslaw.com
844-916-0895
The Chemours Company (NYSE: CC) Investigation:
On Feb. 28, 2024, more questions concerning the propriety of Chemours' statements concerning its historical financial performance were raised, when the Company suspended a slew of its most senior executives pending an internal accounting probe.
Specifically, Chemours announced that it placed CEO (Mark Newman), CFO (Jonathan Lock), and CAA (Camela Wisel) on administrative leave pending completion of an internal accounting review. The scope of the investigation "includes the processes for reviewing reports made to the Chemours Ethics Hotline, the Company's practices for managing working capital, including the related impact on metrics within the Company's incentive plans, and certain non-GAAP metrics included in filings made with the Securities and Exchange Commission or otherwise publicly released, and related disclosures."
The company also announced that, as a result of the foregoing, it is investigating the effectiveness of "'tone at the top' set by certain members of senior management[.]"
This news follows Chemours' Feb. 13, 2024 announcement that it postponed the release of its financial results and conference call related to its Q4 and FYE Dec. 31, 2023. The company revealed then that it "is evaluating its internal control over financial reporting as of December 31, 2023 with respect to maintaining effective controls related to information and communications." The company also revealed that its "Audit Committee also needs additional time to complete a related internal review."
Each of the above announcements drove the price of Chemours shares crashing lower.
If you invested in The Chemours Company and have substantial losses, or have knowledge that may assist the firm's investigation, submit your losses now »
If you'd like more information and answers to frequently asked questions about the Chemours investigation, read more »
Whistleblowers: Persons with non-public information regarding The Chemours Company should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email CC@hbsslaw.com.
# # #
About Hagens Berman
Hagens Berman is a global plaintiffs' rights complex litigation law firm focusing on corporate accountability through class-action law. The firm is home to a robust securities litigation practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and fraud. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Contact:
Reed Kathrein, 844-916-0895
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/200587
